Nirav S. Shah

Nirav S. Shah

Infectious Disease
2050 Pfingsten Rd.
Suite 360
Glenview, IL 60026

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.

Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 08, 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases
Published: April 05, 2026

Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial.

Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial.

Journal: JAMA neurology
Published: November 10, 2025

Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial.

Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial.

Journal: medRxiv : the preprint server for health sciences
Published: October 01, 2025

Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial.

Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial.

Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2025

Treatment Recommendations for Clinical Deterioration on the Wards: Development and Validation of Machine Learning Models.

Treatment Recommendations for Clinical Deterioration on the Wards: Development and Validation of Machine Learning Models.

Journal: JMIR AI
Published: August 04, 2025

Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.

Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.

Journal: JAMA internal medicine
Published: July 14, 2025

Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning Score.

Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning Score.

Journal: Critical care explorations
Published: March 26, 2025

Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.

Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.

Journal: JAMA network open
Published: October 18, 2024

Development and Validation of a Machine Learning Model for Early Detection of Untreated Infection.

Development and Validation of a Machine Learning Model for Early Detection of Untreated Infection.

Journal: Critical care explorations
Published: October 11, 2024

Causes, Diagnostic Testing, and Treatments Related to Clinical Deterioration Events Among High-Risk Ward Patients.

Causes, Diagnostic Testing, and Treatments Related to Clinical Deterioration Events Among High-Risk Ward Patients.

Journal: Critical care explorations
Published: October 02, 2024

Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial.

Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial.

Journal: JAMA cardiology
Published: September 11, 2024
Showing 1-12 of 37

Last Updated: 09/26/2026